TCT 60: Acute-phase Lipid-lowering Effects of Evolocumab in Patients with AMI; Pre-specified Secondary Analysis of the EVO-STEMI Trial
We Recommend
Disclosures
<p>Nothing to disclose</p>
New at TCTMD? Register today!
Enter the email you used to register to reset your password.